WhiteLab Genomics

Series-B+
whitelabgx.com AI & Machine Learning Paris, France 52 employees
Total Funding $26.5M
Latest Round $26M Series-B+
Last Announced Oct 5, 2026
Investors 7 Backers
Decision Makers 6 Verified

About WhiteLab Genomics

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Series-B+
Global Headquarters Paris, France
Team Size 52 employees
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website whitelabgx.com
Domain Registered Date Feb 7, 2019

Social & Network Presence

X / Twitter Profile @WhitelabG (225 followers) Created on Jan 2019
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $26,000,000 · Series-B+

    european-biotechnology.com

  2. Capital Raise

    Series-A announced

    fundraisingfox.com

  3. Milestone

    Website domain registered

    whitelabgx.com

  4. Milestone

    X account created (@WhitelabG)

    225 followers

Investors & Backers

7
AVP
Blast. Club
Debiopharm Group
Debiopharm Innovation Fund
OMNES Capital
Y Combinator
YADAY

Funding History

3 Rounds
Series-B+ · Oct 5, 2026
Series-A · Sep 13, 2022
Venture Round · Undisclosed
$500,000 Source

Founders & Leadership

4

Cedric Odje

Founder

Work email & phone locked Unlock →

David Del Bourgo

CEO co-founder

Work email & phone locked Unlock →

Julien Cottineau

Founder

Work email & phone locked Unlock →

Lucia Cinque

Co-Founder & Chief of Staff

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts